Month: July 2016

Home » Archives for July 2016

‘Bad’ Carbs, Sugary Drinks Heightens Risk Of Cancer

Diet / By / / 1 minute of reading

A new study conducted by the American Society for Nutrition reveals that eating a lot of processed carbohydrates and sugary drinks augment the risk of certain cancers such as prostate cancer and breast cancer. Processed carbohydrates in sweet food and snacks as well as sugary drinks like juices and soda may not directly ’cause’ cancer but the connection between those types of food and the increased risk in prostate and breast cancer are hard to ignore. Read the article.

‘Bad’ Carbs, Sugary Drinks Heightens Risk Of Cancer Read More »

Common prostate cancer treatments suppress immune response and may promote relapse

Research News / By / / 1 minute of reading

Researchers using mouse models found that many medical androgen deprivation therapies (ADTs) – the most commonly used nonsurgical treatments for prostate cancer – may suppress patients’ adaptive immune responses, preventing immunotherapies from working if both treatments are used but not sequenced properly. Read the article.

Common prostate cancer treatments suppress immune response and may promote relapse Read More »

Comparative Effectiveness of Targeted Prostate Biopsy Using MRI-US Fusion Software and Visual Targeting

Diagnosis / By / / 1 minute of reading

A study compared diagnostic outcomes between 2 different techniques for targeting regions-of-interest on prostate multiparametric Magnetic resonance imaging (mpMRI); MRI-ultrasound fusion (MR-F) and visually targeted (VT) biopsy. No evidence was found of a significant difference in the detection of high-grade or any-grade cancer between VT and MR-F biopsy. However, the performance of each technique varied in specific biopsy locations, and the outcomes of both techniques were complementary. Combining VT biopsy and MR-F biopsy may optimize prostate cancer detection. Read the article.

Comparative Effectiveness of Targeted Prostate Biopsy Using MRI-US Fusion Software and Visual Targeting Read More »

Prostate Ca: Site of metastases impacts prognosis

Diagnosis / By / / 1 minute of reading

In a study of 8,820 men with metastatic castration-resistant prostate cancer, researchers found the prognosis differs substantially based on where the cancer has spread. Spread to the liver is associated with shorter survival than lung and bone spread, and patients with lymph node metastases only have the best overall survival. Read the article.

Prostate Ca: Site of metastases impacts prognosis Read More »

Scroll to Top